Itau Unibanco Holding S.A. Neogenomics Inc Transaction History

Itau Unibanco Holding S.A.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$11.67 - $20.73 $1,505 - $2,674	-129 Reduced 23.41%	422 $6,000
Q2 2023 Aug 14, 2023	BUY	$14.1 - $19.83 $7,769 - $10,926	551 New	551 $8,000
Q2 2022 Aug 15, 2022	SELL	$7.06 - $13.97 $4,130 - $8,172	-585 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$12.15 - $35.28 $291 - $846	24 Added 4.28%	585 $7,000
Q4 2021 Feb 14, 2022	BUY	$30.49 - $48.49 $4,238 - $6,740	139 Added 32.94%	561 $19,000
Q3 2021 Nov 12, 2021	BUY	$41.66 - $52.52 $458 - $577	11 Added 2.68%	422 $20,000
Q2 2021 Aug 17, 2021	BUY	$36.62 - $51.69 $15,050 - $21,244	411 New	411 $19,000

295

125M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.13B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Itau Unibanco Holding S.A. with notifications on news.